SCHEMBL1634190

SCHEMBL1634190

N#Cc1ccc(Oc2cccc3cnc(Nc4ccc(S(N)(=O)=O)cc4)nc23)cc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ IKBKB O14920 9/20 0.53
▸ KCNH2 Q12809 1/20 0.47
▸ SCN5A Q14524 1/20 0.47
▸ SCN9A Q15858 1/20 0.47
▸ CDK2 P24941 3/20 0.47
▸ CDK1 P06493 3/20 0.47
▸ KDR P35968 2/20 0.47
▸ GSK3B P49841 2/20 0.47
▸ CDC7 O00311 1/20 0.47
▸ PLK4 O00444 1/20 0.47
▸ CHEK1 O14757 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ DCLK1 O15075 1/20 0.47
▸ MAPK13 O15264 1/20 0.47
▸ PDPK1 O15530 1/20 0.47
▸ DAPK3 O43293 1/20 0.47
▸ DYRK3 O43781 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ ROCK2 O75116 1/20 0.47
▸ RPS6KA5 O75582 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1634182 0.87 CA1 (0.60) IKBKBCDK2CDK1GSK3BAURKA
SCHEMBL1633446 0.87 IKBKB (0.56) IKBKBCDK2JAK2TYK2JAK3
SCHEMBL1633962 0.83 IKBKB (0.51) IKBKBCDK2CDK1GSK3BAURKA
SCHEMBL1632825 0.81 IKBKB (0.48) IKBKBCDK2CDK1GSK3BJAK2
SCHEMBL1633814 0.81 EGFR (0.55) IKBKBCDK2CDK1GSK3BJAK2
SCHEMBL1633413 0.80 CA1 (0.47) IKBKBCDK2CDK1KDRGSK3B
SCHEMBL1632432 0.80 CYP1A2 (0.48) IKBKBCDK2CDK1GSK3BAURKA
SCHEMBL1633821 0.79 STK4 (0.52) IKBKBCDK2CDK1AURKADCLK1
SCHEMBL1633262 0.79 IKBKB (0.49) IKBKBCDK2CDK1KDRGSK3B
SCHEMBL1632814 0.77 CDK2 (0.52) IKBKBCDK2CDK1KDRJAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
US-7932262-B2 Quinazolines for PDK1 inhibition NOVARTIS AG (CH) 2011-04-26 — — US disclosed
Send feedback